Pancréas

TITRE (EN) A Randomized Controlled Trial of Endoscopic Ultrasound Guided Celiac Plexus Neurolysis (EUS-CPN) With and Without Bupivacaine
PROTOCOLE ID 21.151
CLINICAL TRIAL.gov ID NCT04951804
TYPE(S) DE CANCER Pancréas
PHASE Autres
TYPE D'ÉTUDE Clinique
INSTITUTION CHUM
1051 rue Sanguinet
(514) 890-8000
VILLE Montréal
INVESTIGATEUR(RICE) PRINCIPAL(E) Anand Sahai
COORDONATEUR(RICE) Charles Mackay
charles.mackay.chum@ssss.gouv.qc.ca
514-890-8000 poste 36484
STATUT  Actif en recrutement
CRITÈRES D'ÉLIGIBILITÉ (EN)
  • Malignant-appearing pancreatic mass, or proven pancreatic cancer involving the pancreatic genu, body, or tail

  • Any level of abdominal or back pain considered to be potentially related to the mass:

    • New onset pain (<3 months)
    • Constant
    • Centrally located
    • With or without irradiation to the back
    • No obvious other source of pain based on history and physical examination by the attending endosonographer
  • No possibility of surgical management
  • Signed, informed consent
  • Celiac axis accessible for bilateral neurolysis at EUS.
CRITÈRES D'EXCLUSION (EN)
  • Allergy to bupivacaine